Thrombopoietic Agents for the Treatment of Persistent and Chronic Immune Thrombocytopenia in Children

Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial

David J. Kuter, James B. Bussel, Roger M. Lyons et al. · The Lancet · 2008 · 862 citations

Medicine, Hematology, Pharmacology +6

Eltrombopag for the Treatment of Chronic Idiopathic Thrombocytopenic Purpura

James B. Bussel, Gregory Cheng, Mansoor N. Saleh et al. · New England Journal of Medicine · 2007 · 805 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

European consensus on grading bone marrow fibrosis and assessment of cellularity.

Jürgen Thiele, Hans Michael Kvasnicka, Fabio Facchetti et al. · PubMed · 2005 · 770 citations

Medicine, Pathology, Hematopathology +15

Eltrombopag for management of chronic immune thrombocytopenia (RAISE): a 6-month, randomised, phase 3 study

Gregory Cheng, Mansoor N. Saleh, Claus Werenberg Marcher et al. · The Lancet · 2010 · 582 citations · Full text

Medicine, Hematology, Pharmacotherapy +7

Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial

James B. Bussel, Drew Provan, Tahir Shamsi et al. · The Lancet · 2009 · 539 citations

Medicine, Hematology, Pharmacotherapy +10